![Fred Biehl](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fred Biehl
Directeur/Membre du Conseil chez Aspargo Laboratories, Inc.
Postes actifs de Fred Biehl
Sociétés | Poste | Début | Fin |
---|---|---|---|
Aspargo Laboratories, Inc.
![]() Aspargo Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Aspargo Laboratories, Inc. is a clinical stage pharmaceutical company, which focuses on developing an oral spray formulation of sildenafil. Its products include Sildenafil Oral Spray, an oral liquid suspension of sildenafil citrate administered via a spray pump that dispenses 12.5 mg of sildenafil per push of the pump or via an individual single liquid unit dispensing 100 mg per unit. The company was founded in 2019 and is headquartered in Englewood Cliffs, NJ. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Fred Biehl
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Aspargo Laboratories, Inc.
![]() Aspargo Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Aspargo Laboratories, Inc. is a clinical stage pharmaceutical company, which focuses on developing an oral spray formulation of sildenafil. Its products include Sildenafil Oral Spray, an oral liquid suspension of sildenafil citrate administered via a spray pump that dispenses 12.5 mg of sildenafil per push of the pump or via an individual single liquid unit dispensing 100 mg per unit. The company was founded in 2019 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
- Bourse
- Insiders
- Fred Biehl
- Expérience